Cardiff Lexington Corporation (CDIF) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Cardiff Lexington Corporation  (CDIF)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Cardiff Lexington's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cardiff Lexington's ROI in the second quarter of 2026?
Cardiff Lexington Corporation recorded a cumulative net loss of $-9 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -91.04%.

Within the Healthcare sector 594 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3456 to 4202.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 60.33 % -40.71 % -44.18 % -27.55 % -19.34 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 27 6 3 5 5
Return On Investment (TTM) -91.04 % -171.74 % -116.75 % -63.11 % -70.89 %
CDIF's Overall Ranking # 4202 # 3456 # 2763 # 3369 # 3526
Seq. Investment Change TTM 117.62 % 0.58 % -20.23 % -8.18 % -19.53 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -9 -8 -6 -4 -5




Return On Investment CDIF's Ranking
Within: No.
Industry # 30
Sector # 595
Overall # 4202

Return On Investment Statistics
High Average Low
144.67 %
-37.61 %
-171.74 %
(Jun 30 2022)   (Mar 31 2026)







Financial Statements
Cardiff Lexington's II. Quarter Investments $ 27 Millions CDIF's Balance sheet
Cardiff Lexington's II. Quarter Income $ -2 Millions Quarterly CDIF's Income Statement
CDIF's Income by Division See CDIF's Income by Division


CDIF Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 3 8 7 3 3
Y / Y Investment Growth -59.51 % 16.76 % 103.71 % 10.95 % -
Net Income in Millions -6 -3 3 -5 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -169.23 % -41.09 % 43.98 % -160.64 % -13.45 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CDIF's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CDIF's Competitors
Subscribers only: Roi for Cardiff Lexington's Suppliers
Subscribers only: Return On Investment for CDIF's Customers

Other Ratios
CDIF's Roa CDIF's Inventory Turnover Ratio CDIF's Growth Rates CDIF's Dividend Statistics
CDIF's Profitability Ratios CDIF's Asset Turnover Ratio CDIF's Dividend Growth
CDIF's Roe CDIF's Valuation Ratios CDIF's Financial Strength Ratios CDIF's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-26T07:31:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.